11.18.2024 - Extended Benefit

from QuadShot News Podcast · host Caleb Dulaney, Laura Dover, Sam Marcrom

Check out this week's QuadCast as we highlight the oncologic benefit of extended nodal dissection for prostate cancer, the comparison of Durvalumab and Cetuximab in cisplatin-ineligible H&N cancer patients, the high incidence of psoriasis development on immunotherapy, and more. Check out the website and subscribe to the newsletter! www.quadshotnews.com Founders & Lead Authors: Laura Dover & Caleb Dulaney Podcast Host: Sam Marcrom

Episode metadata supplied by the publisher feed · Published Nov 18, 2024

Embed this episode

Attribution link and audio player

What this episode covers

Distinct summary based on available episode metadata or transcript content.

Ready to play

11.18.2024 - Extended Benefit

0:00 9:43

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of QuadShot News Podcast?

This episode is 9 minutes long.

When was this QuadShot News Podcast episode published?

This episode was published on November 18, 2024.

Can I download this QuadShot News Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!